ST Pharm Co.,Ltd.

₩72,600As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:237690Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 5.23%
Div yield 0.69%
ROE 13.61%
Medical (Pharmaceuticals)
Beta (5Y) 0.53
PE TTM 19.92
TSR TTM (28.11%)
Mkt cap ₩1.516T
ROIC 12.40%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩78,144
7.64%
(4.45%)
Hold 2|5|11|5|0
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
1,056
1,055
1,157
1,101
25.32%
12.60%
22.23%
13.70%
Revenue₩B
114.6
111.9
116.6
121.9
11.25%
6.52%
9.33%
10.86%
Peers (US$1.117B)
Cap (US$)
PE
1.024B
14.77x
1.231B
11.19x
Capital
TTM
5Y
10Y
Leveragex
2.617
0.436
0.449
EBIT/Intx
1.149
1.445
1.286
Own earn%
(405.87)
37.99
30.65
Sh yield%
19.59
44.91
46.74
Owners
Insiders/Inst%
3.49
71.50
Short interest%
4.03
SBC / revenue%
0.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
0–8
$1 testx
—
Incr. ROIC%
1